Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Pediatrics in Review. 2009;30:e22-e28. doi:10.1542/10.1542/pir.30-4-e22)
© 2009 American Academy of Pediatrics

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Rapid Responses: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Levy, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Levy, P. A.
Related Collections
Right arrow Metabolic Disorders
Right arrow Neurologic Disorders
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Inborn Errors of Metabolism

Part 2: Specific Disorders


Paul A. Levy, MD*
* Assistant Professor of Pediatrics and Pathology, Children's Hospital at Montefiore, Bronx, NY

Abbreviations: ALD: adrenoleukodystrophy • AMN: adrenomyeloneuropathy • CACT: carnitine acylcarnitine translocase • CNS: central nervous system • CPK: creatine phosphokinase • CPS: carbamyl phosphate synthetase • CPT: carnitine palmitoyltransferase • CSF: cerebrospinal fluid • GSD: glycogen storage disease • LCAD: long-chain acyl-coA dehydrogenase • LCFA: long-chain fatty acid • MCAD: medium-chain acyl-coA dehydrogenase • MLD: metachromatic leukodystrophy • MPS: mucopolysaccharidosis • mtDNA: mitochondrial DNA • NAGS: N-acetyl glutamate synthetase • nDNA: nuclear DNA • OTC: ornithine transcarbamylase • OXPHOS: oxidative phosphorylation • RCDP: rhizomelic chondroplasia punctuate • SCAD: short-chain acyl-coA dehydrogenase • VLCAD: very long-chain acyl-coA dehydrogenase • VLCFA: very long-chain fatty acids

The first 300 words of the full text of this article appear below.

The following article is included online only as a second part of the article "Inborn Errors of Metabolism: Part 1."


    Amino Acid Disorders
 
There is no one prototypical disorder of amino acid metabolism; each disorder has its own unique collection of symptoms. Four well-described amino acid disorders have been chosen as examples of this group.

Phenylketonuria, a disorder of phenylalanine metabolism, leads to intellectual disability if untreated.

Maple syrup urine disease involves an enzyme common to the degradation of the branched-chain amino acids (leucine, isoleucine, and valine). Although there are five subtypes of maple syrup urine disease, the classic form has a neonatal onset and generally progresses from poor feeding to coma and death if not treated.

Tyrosinemia also has multiple subtypes. Hepatorenal tyrosinemia (type I) may present with liver failure (elevated transaminase concentrations, hyperbilirubinemia, coagulopathy, ascites, and gastrointestinal bleeding) as well as kidney involvement (tubular dysfunction) and peripheral nerve involvement (painful crises, weakness or paralysis). Type II tyrosinemia is an oculocutaneous form of the disease that has corneal lesions and skin findings.

Homocystinuria, most commonly caused by cystathionine beta-synthase deficiency, presents with ocular (ectopia lentis), skeletal (marfanoid features such as dolichostenomelia and arachnodactyly), vascular (thromboembolic), and central nervous system (intellectual disability, stroke, and seizures) abnormalities.

When an amino acid disorder is suspected, measurement of plasma amino acids generally is sufficient to make the diagnosis. Assessment of urine amino acids can be helpful for homocystinuria and some abnormalities of amino acid transport (cystinuria, dicarboxylic amino aciduria) that affect the kidneys and for detecting generalized amino aciduria found with some kidney disease and mitochondrial disorders.


    Urea Cycle Disorders
 
The degradation of amino acids results in their deamination, generating ammonia as the waste nitrogen. The urea cycle removes the excess ammonia by generating urea, which is eliminated in the urine. Six disorders of the urea cycle are known. . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?





HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics  Pediatrics in Review
Copyright © 2009 by the American Academy of Pediatrics.